Skip to main content
OpenTrials

Clinical trial condition

Endometrial Adenocarcinoma

Explore clinical trials studying Endometrial Adenocarcinoma. Study availability and eligibility vary by location and protocol.

47 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Adenocarcinoma trial results

Recruiting

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

NCT05112601

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +28 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University Cancer and Blood Center LLC Athens, Georgia, United States
  • Augusta University Medical Center Augusta, Georgia, United States
  • Saint Alphonsus Cancer Care Center-Boise Boise, Idaho, United States
View all 137 locations
View Trial Details
Recruiting

DBC-664 in Adult Patients With Solid Tumors

NCT07705035

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +14 more
Locations
  • START Midwest Grand Rapids, Michigan, United States
  • START New Jersey East Brunswick, New Jersey, United States
  • START New York Lake Success, New York, United States
View Trial Details
Recruiting

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

NCT05548296

Conditions
Endometrial Adenocarcinoma, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Alaska Women's Cancer Center Anchorage, Alaska, United States
  • HonorHealth Phoenix, Arizona, United States
  • Arizona Oncology Associate, PC- HOPE Tucson, Arizona, United States
View all 91 locations
View Trial Details
Recruiting

A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

NCT06399757

Conditions
Adenocarcinoma, Adenocarcinoma, Mucinous, Adnexal Diseases, +46 more
Locations
  • City of Hope Duarte, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
  • University of Michigan Ann Arbor, Michigan, United States
View Trial Details

Related conditions